Integral Investment Advisors’s PepsiCo PEP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$690K Hold
5,097
0.15% 89
2026
Q1
$792K Hold
5,097
0.2% 80
2025
Q4
$732K Buy
5,097
+119
+2% +$17.5K 0.18% 84
2025
Q3
$699K Hold
4,978
0.19% 84
2025
Q2
$657K Sell
4,978
-287
-5% -$38.7K 0.19% 86
2025
Q1
$789K Sell
5,265
-194
-4% -$28.9K 0.25% 73
2024
Q4
$830K Sell
5,459
-64
-1% -$10.5K 0.27% 72
2024
Q3
$939K Hold
5,523
0.31% 68
2024
Q2
$918K Buy
5,523
+3
+0.1% +$518 0.34% 65
2024
Q1
$958K Buy
5,520
+2,546
+86% +$429K 0.4% 51
2023
Q4
$505K Buy
2,974
+364
+14% +$60.4K 0.32% 54
2023
Q3
$442K Buy
2,610
+64
+3% +$11.6K 0.31% 55
2023
Q2
$472K Hold
2,546
0.32% 52
2023
Q1
$464K Hold
2,546
0.33% 52
2022
Q4
$460K Hold
2,546
0.36% 50
2022
Q3
$416K Hold
2,546
0.34% 61
2022
Q2
$424K Sell
2,546
-407
-14% -$68.5K 0.36% 58
2022
Q1
$494K Buy
2,953
+557
+23% +$93.5K 0.31% 63
2021
Q4
$416K Buy
+2,396
New +$391K 0.3% 66

Other funds holding PEP

Integral Investment Advisors's PEP Position: Q2 2026 in Review

Integral Investment Advisors held its PepsiCo (PEP) position steady in Q2 2026 at 5,097 shares worth $690K. The position accounts for 0.15% of the portfolio, ranked #89.

Integral Investment Advisors first reported a position in PEP in Q4 2021 and has held it in 19 quarters since. The position peaked at $958K in Q1 2024. 3,398 funds tracked by Wall St. Rank hold PEP as of Q2 2026.

  • Integral Investment Advisors held 5,097 shares of PepsiCo worth $690K as of Q2 2026.
  • Integral Investment Advisors left its PepsiCo share count unchanged in Q2 2026.
  • PepsiCo made up 0.15% of Integral Investment Advisors's portfolio in Q2 2026, its #89 holding.
  • Integral Investment Advisors first reported a position in PepsiCo in Q4 2021 and has held it in 19 quarters since.
  • Integral Investment Advisors's PepsiCo position peaked at $958K in Q1 2024.
  • 3,398 funds tracked by Wall St. Rank held PepsiCo as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.